Page last updated: 2024-10-25

deferoxamine and Retinitis Pigmentosa

deferoxamine has been researched along with Retinitis Pigmentosa in 5 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Retinitis Pigmentosa: Hereditary, progressive degeneration of the retina due to death of ROD PHOTORECEPTORS initially and subsequent death of CONE PHOTORECEPTORS. It is characterized by deposition of pigment in the retina.

Research Excerpts

ExcerptRelevanceReference
"Eight patients (16 eyes) developed ocular toxicity while undergoing intravenous deferoxamine mesylate (Desferal) chelation therapy for transfusional hemosiderosis."3.67Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy. ( Jiji, R; Lakhanpal, V; Schocket, SS, 1984)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dunaief, JL1
Obolensky, A1
Berenshtein, E1
Lederman, M1
Bulvik, B1
Alper-Pinus, R1
Yaul, R1
Deleon, E1
Chowers, I1
Chevion, M1
Banin, E1
Lu, M1
Hansen, RM1
Cunningham, MJ1
Eklund, SE1
Fulton, AB1
Lakhanpal, V1
Schocket, SS1
Jiji, R1
Bournerias, F1
Monnier, N1
Dufier, JL1
Réveillaud, RJ1

Other Studies

5 other studies available for deferoxamine and Retinitis Pigmentosa

ArticleYear
Ironing out neurodegeneration: iron chelation for neuroprotection.
    Free radical biology & medicine, 2011, Oct-15, Volume: 51, Issue:8

    Topics: Animals; Chelating Agents; Deferoxamine; Humans; Iron; Organometallic Compounds; Retina; Retinitis P

2011
Zinc-desferrioxamine attenuates retinal degeneration in the rd10 mouse model of retinitis pigmentosa.
    Free radical biology & medicine, 2011, Oct-15, Volume: 51, Issue:8

    Topics: Animals; Biomarkers; Chelating Agents; Cyclic Nucleotide Phosphodiesterases, Type 6; Deferoxamine; D

2011
Effects of desferoxamine on retinal and visual function.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2007, Volume: 125, Issue:11

    Topics: Adult; beta-Thalassemia; Deferoxamine; Female; Humans; Retina; Retinitis Pigmentosa; Scotoma; Sidero

2007
Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy.
    Ophthalmology, 1984, Volume: 91, Issue:5

    Topics: Aged; Blood Transfusion; Color Perception; Deferoxamine; Female; Hemosiderosis; Humans; Male; Middle

1984
[Severe ocular toxicity of desferrioxamine in the hemodialyzed patient].
    Nephrologie, 1987, Volume: 8, Issue:1

    Topics: Aged; Aluminum; Deferoxamine; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Retinitis Pigme

1987